Yissum agreement, page-10

From my own perspective bioavailability is the highest effective biomedical quality of a product that can be provided to the patients specific condition. As an example a patient who has joint discomfort can be subscribed the precise formula of compounds to control the indication at the highest potential.

The compounds in cannabis are complex and will consistently improve through further study and trialling, even as far as providing a medical product personalised to the specific patient. Such as if 2 people were to suffer from epilepsy, the medical subscription would be customised dependant on the biological structure of the patient (genome).

It is complex but already happening.